ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

VRPX Virpax Pharmaceuticals Inc

2.21
-0.02 (-0.90%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Virpax Pharmaceuticals Inc VRPX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.02 -0.90% 2.21 10:00:00
Open Price Low Price High Price Close Price Previous Close
2.30 2.24 2.66 2.24 2.23
more quote information »

Recent News

Date Time Source Heading
30/4/202421:30BWVirpax Announces Results of Maximum Tolerated Dose Study for..
26/3/202422:30BWVirpax Pharmaceuticals Reports 2023 Year-End Results
27/2/202423:31BWVirpax Pharmaceuticals Announces Reverse Stock Split to..
27/2/202423:30BWVirpax Pharmaceuticals Announces Proposed Settlement of..
07/2/202423:30BWVirpax Pharmaceuticals Announces Preliminary Results of..
01/2/202408:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202408:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202408:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202408:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202408:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202408:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202408:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202408:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202323:30EDGAR2Form 8-K - Current report
29/12/202323:30BWVirpax Pharmaceuticals Announces Results of Special..
14/12/202300:30EDGAR2Form 8-K - Current report
08/12/202301:08EDGAR2Form DEF 14A - Other definitive proxy statements
08/12/202300:58EDGAR2Form 8-K - Current report
08/12/202300:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
22/11/202308:57EDGAR2Form PRE 14A - Other preliminary proxy statements
17/11/202323:30EDGAR2Form 8-K - Current report
17/11/202323:15EDGAR2Form 8-K - Current report
17/11/202323:10BWVirpax Pharmaceuticals Announces Notification from Nasdaq..
17/11/202323:00BW Virpax Pharmaceuticals Announces Leadership Transition
17/11/202308:51EDGAR2Form 8-K - Current report
16/11/202308:15BWVirpax Pharmaceuticals Reports 2023 Third Quarter Results..
16/11/202307:03EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
31/10/202323:58BWVirpax Pharmaceuticals Announces that Envelta™ Remains on..
12/10/202323:02BWVirpax Pharmaceuticals Announces Extension of CRADA with the..
12/10/202307:10EDGAR2Form 8-K - Current report
04/10/202300:51EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/10/202323:58BWGerald W. Bruce Appointed President and CEO of Novvae™..
27/9/202322:58BWVirpax Pharmaceuticals Announces Results of Probudur™ Dose..
26/9/202322:58BWVirpax Pharmaceuticals to Present at the LD Micro Main Event..
22/9/202303:35BWAltasciences von Virpax ausgewählt, um die Entwicklung eines..
22/9/202303:18BWAltasciences choisi par Virpax pour soutenir le..
22/9/202300:00BWAltasciences Chosen by Virpax to Support the Development of..
18/9/202321:58BWVirpax Pharmaceuticals Announces the Formation of Novvae™..
05/9/202323:28EDGAR2Form 8-K - Current report
05/9/202323:00BWVirpax Pharmaceuticals Updates on Litigation
28/8/202322:58BWVirpax® Pharmaceuticals to Present at H.C. Wainwright 25th..
17/8/202307:00EDGAR2Form 8-K - Current report
17/8/202307:00EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
14/8/202323:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202323:05EDGAR2Form 8-K - Current report
14/8/202323:00BWVirpax Pharmaceuticals Reports 2023 Second Quarter Results..
10/8/202322:58BWVirpax Pharmaceuticals Files Provisional Patent Application..
27/7/202306:10EDGAR2Form 8-K - Current report
24/7/202321:00BWVirpax Pharmaceuticals, Inc. to Ring NASDAQ Closing Bell on..
13/7/202322:58BWVirpax Pharmaceuticals Files Provisional Patent Application..

Your Recent History

Delayed Upgrade Clock